Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
暂无分享,去创建一个
W. Catalona | C. Thaxton | S. Loeb | K. Roehl
[1] John T. Wei,et al. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. , 2006, Journal of the National Cancer Institute.
[2] P. Walsh,et al. Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The Journal of urology.
[3] K. Harada,et al. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ‐confined disease , 2005, International journal of urology : official journal of the Japanese Urological Association.
[4] Alan W Partin,et al. Characteristics of insignificant clinical T1c prostate tumors , 2004, Cancer.
[5] Yan Yan,et al. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? , 2004, Urology.
[6] Hartwig Huland,et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. , 2003, The Journal of urology.
[7] A. Partin,et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. , 2003, Urology.
[8] R T Vollmer,et al. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[9] P. Walsh,et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.
[10] A S Whittemore,et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.